Clinical Trials Directory

Trials / Conditions / Pre-Exposure Prophylaxis

Pre-Exposure Prophylaxis

59 registered clinical trials studyying Pre-Exposure Prophylaxis9 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingIntervention to Reduce Implicit Bias in Pharmacies
NCT06487351
Massachusetts General HospitalN/A
RecruitingUniversal Test and Connect for HIV Service Delivery in South Africa
NCT06408142
Johns Hopkins University
RecruitingGathering Online for Dialogue and Discussion to Enhance Social Support
NCT05753683
RTI InternationalN/A
RecruitingThailand HIV and Stigma Reduction Study
NCT06576648
University of Massachusetts, WorcesterN/A
Active Not RecruitingCentering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero
NCT05929521
University of Illinois at ChicagoEARLY_Phase 1
CompletedEnhancing Communication on Relationship Preservation, Safer Conception and PrEP to Promote HIV Testing in Ugan
NCT06647797
Children's Mercy Hospital Kansas CityN/A
SuspendedHIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men
NCT06183502
Emory University
Active Not RecruitingZambia Healthy Choices Project for Emerging Adults Living With HIV
NCT06415357
University of Massachusetts, WorcesterN/A
RecruitingUNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126
University of North Carolina, Chapel HillPhase 4
CompletedProject Phakama: Testing Support Strategies to Empower Young Women on PrEP in South Africa
NCT06274060
Johns Hopkins Bloomberg School of Public HealthN/A
CompletedImproving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi
NCT06200545
HIV Prevention Trials NetworkN/A
UnknownScreening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV (ANAPreP'HPV)
NCT06296602
Centre Hospitalier Universitaire de BesanconN/A
RecruitingPredictors of Health Service Utilizations Among Key Population in Washington DC
NCT06046079
Us Helping Us, People Into Living, Inc.
CompletedInformation Seeking About Pre-exposure Prophylaxis
NCT05728034
Penn State UniversityN/A
CompletedDevelopment and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore
NCT05614492
Johns Hopkins Bloomberg School of Public HealthN/A
CompletedFriendship Bench Mental Health Intervention for Adolescent Girls and Young Women in South African PrEP Deliver
NCT05664490
University of California, San FranciscoN/A
CompletedPilot Mobile Medical Unit Study for I'm Fully Empowered4Her
NCT05644834
University of North Carolina, Chapel HillN/A
TerminatedHIV Pre-Exposure Prophylaxis Among an Unrecognized Sexual Minority Population
NCT05815030
The Alternative Sexualities Health Research AllianceN/A
CompletedNext Generation Ingestible Sensors for Medication Adherence Measurement
NCT05592613
Brigham and Women's HospitalPhase 3
CompletedLe Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South Afric
NCT05417620
Johns Hopkins Bloomberg School of Public HealthN/A
RecruitingCase Management Dyad
NCT06162897
University of ChicagoN/A
CompletedThe Blued+ Combination HIV Prevention Pilot Study in China
NCT06647173
Emory University
CompletedAssessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users
NCT05395754
Louisiana State University Health Sciences Center in New OrleansN/A
RecruitingHybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
NCT05856942
University of WashingtonN/A
CompletedDeveloping mHealth to Promote PrEP Use Among Thai Young Men Who Have Sex With Men
NCT05243030
University of Massachusetts, WorcesterN/A
CompletedPrEPTECH Phase 2 Study of a PrEP Telehealth Intervention
NCT04902820
ETR AssociatesN/A
CompletedTesting Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in Kenya
NCT05482360
University of WashingtonN/A
Active Not RecruitingDeveloping mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults
NCT05262426
University of Massachusetts, WorcesterN/A
RecruitingStick2PrEP Cisgender Women and Trans Individuals
NCT05165745
Columbia UniversityN/A
CompletedLeveraging Electronic Health Record Data in a Risk Prediction Model to Increase HIV PrEP Intake in Primary Car
NCT05991869
Kaiser PermanenteN/A
CompletedPrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency
NCT04712994
University of WashingtonN/A
WithdrawnmHealth Facilitated Intervention to Improve HIV Pre-Exposure Prophylaxis Adherence
NCT04990583
Rhode Island HospitalN/A
CompletedCommunity-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot
NCT04222504
Massachusetts General HospitalN/A
CompletedPrEP Readiness Interventions for Supporting Motivation
NCT04205487
Florida International UniversityN/A
CompletedThe Development of a Mobile-based App to Increase Uptake of Pre-Exposure Prophylaxis (PrEP) by Men Who Have Se
NCT04426656
University of North Carolina, Chapel HillN/A
CompletedmHealth Technologies to Enhance PrEP Adherence Among Thai MSM
NCT04413708
Duke UniversityN/A
CompletedDesign and Development of a Mobile App to Improve Adherence to Pre-exposure Prophylaxis in Men Who Have Sex Wi
NCT04248790
National Cheng Kung UniversityN/A
CompletedCOVID-19 Infection in Patients Infected With HIV and/or on PrEP
NCT04379245
Hospices Civils de Lyon
TerminatedDoes Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?
NCT04374942
Megan LandesPhase 3
CompletedComparison of Men's Prevention Apps to Research Efficacy
NCT03965221
Public Health Foundation Enterprises, Inc.N/A
CompletedLinking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
NCT04064567
University of ArkansasN/A
CompletedLife Steps for PrEP for Youth
NCT03805451
Fenway Community HealthN/A
CompletedEvaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region
NCT03995862
Centre Hospitalier Annecy Genevois
CompletedElectronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System
NCT03729570
Emory UniversityN/A
CompletedDOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
NCT03771638
Public Health Foundation Enterprises, Inc.Phase 4
CompletedLYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
NCT03177512
Public Health Foundation Enterprises, Inc.N/A
CompletedIdentification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.
NCT03705663
Medstar Health Research Institute
CompletedPeer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)
NCT04417946
Yale UniversityN/A
CompletedAlignment of PrEP Use With HIV Risk in Young Women and Men
NCT04664998
University of WashingtonPhase 4
CompletedDOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence
NCT03387462
Public Health Foundation Enterprises, Inc.Phase 4
CompletedPeer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV
NCT03226873
Montefiore Medical CenterN/A
CompletedThe Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Comm
NCT03120936
Public Health Foundation Enterprises, Inc.Phase 4
CompletedMobile-Based Application "MyChoices"
NCT03179319
Fenway Community HealthN/A
CompletedAssessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers
NCT03202511
Indiana UniversityEARLY_Phase 1
CompletedOptimizing PrEP Adherence for Young Men Who Have Sex With Men
NCT03493555
Fenway Community HealthN/A
CompletedEffect of Social Media Support and Financial Incentives on PrEP Adherence
NCT03078153
George Washington UniversityN/A
CompletedOptimizing HIV PrEP Through Shared Decision Making
NCT03019770
Beth Israel Deaconess Medical CenterN/A
CompletedHOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing
NCT03138135
Public Health Foundation Enterprises, Inc.N/A
CompletedEvalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With J
NCT00694460
NovartisPhase 2